MariMed (OTC: MRMD)
MariMed Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MariMed Company Info
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
News & Analysis
MariMed (MRMD) Q2 EPS Jumps to Positive
2 Underrated Growth Stocks That Could Double Your Money
The upside these stocks possess may significantly outweigh their risks.
These 3 Trends Will Separate the Winners and Losers of Cannabis Stocks
Legalization doesn't matter as much as it may seem.
2 Cannabis Growth Stocks That Could Double By 2024
They've already started down the road -- now they just need to follow through.
3 Cannabis Stocks That Could Easily Double By 2023
They're small now, but these multistate operators look well-placed to rocket ahead in the marijuana market.
2 Promising Growth Stocks to Buy Before 2022
Although they've been generating strong numbers in 2021, next year these businesses should do even better.
2 Small Cannabis Companies Showing Huge Gains
MariMed and Gage Growth are smaller cannabis companies that are posting big revenue gains. Investors looking for growth might want to get in on these two stocks before they're discovered.
Is This the Most Underrated Pot Stock to Buy Right Now?
The company is coming off a terrific quarter with strong sales and profit numbers, and there is more growth ahead.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.